The Law Offices of Frank R. Cruz Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Inari Medical, Inc. (“Inari” or the “Company”) (NASDAQ: NARI) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On February 28, 2024, Inari announced that it had received a civil investigative demand from the U.S. Department of Justice “in connection with an investigation under the federal Anti-Kickback Statute and Civil False Claims Act” requesting information and documents “primarily relating to meals and consulting service payments provided to health care professionals.”

On this news, Inari’s stock price fell $12.14, or 20.8%, to close at $46.12 per share on February 29, 2024, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Inari securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 at 310-914-5007, by email to [e-mail], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240306720521/en/

The Inari Medical Stock at the time of publication of the news with a raise of +4,70 % to 42,74EUR on Nasdaq stock exchange (06. März 2024, 19:59 Uhr).